JuLib | Articles & more - {"Langen, K. J."}

Bone regeneration induced by a 3D architectured hydrogel in a rat critical-size calvarial defect

Lohmann, P.
2017

Biomaterials, 113 (2017) S. 158 - 169

“...Langen, K.-J....”

2

German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging

Barthel, H.
2016

Nuklearmedizin, 55 (2016) 4, S. 129 - 137

“...Langen, K.-J....”

3

The usefulness of dynamic O-(2-18F-Fluoroethyl)-L-Tyrosine PET in the clinical evaluation of brain tumors in childrenand adolescents.

Dunkl, V.
2015

Journal of Nuclear Medicine Journal of nuclear medicine, 56 56 (2014 2014) 1 1, S. 88-92 88-92

“...Langen, K.-J....”

4

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Langen, K. J....”

5

Abstract

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Langen, K. J....”

6

Role of O-(2-18 F-Fluoroethyl)-L-Tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis

Galldiks, N.
2012

Journal of Nuclear Medicine Journal of nuclear medicine, 53 53 (2012 2012) 9 9, S. 1367-1374 1367-1374

“...Langen, K.J....”

7

Cis-4-[F18]fluoro-D-proline detects secondary thalamic and hippocampal degeneration induced by rat glioma

Klein, S.
2012

“...Langen, K.J....”

8

Assessment of treatment response in patients with glioblastoma using [18F]Fluoroethyl-L-Tyrosine PET in comparison to MRI

Galldiks, N.
2012

Journal of Nuclear Medicine Journal of nuclear medicine, 53 53 (2012 2012) 7 7, S. 1048-1057 1048-1057

“...Langen, K.J....”

9

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: Results of a prospective phase II study

Piroth, M.D.
2012

Strahlentherapie und Onkologie Strahlentherapie und Onkologie: journal of radiati, 188 (2012) S. 334 - 339

“...Langen, K.J....”

10

Hybrid MR-PET bei Patienten mit zerebralen Gliomen: Erste Erfahrungen

Langen, K.-J.
2011

11

Prognostischer Wert der postoperativen FET-PET bei Patienten mit Glioblastom

Filß, C.
2011

“...Langen, K.-J....”

12

Molekulare Mechanismen der O-(2-[F-18]Fluorethyl)-L-tyrosin (FET) spezifischen Anreicherung in Tumorgewebe

Salber, D.S.
2011

“...Langen, K.-J....”

13

Is there unspecific FET-uptake in reactive astrogliosis surrounding cerebral glioma?

Manuvelpillai, J.
2011

“...Langen, K.-J....”

14

(18)F-Fluoroethyltyrosine-PET imaging in glioblastoma patients for radiotherapy planning and response analysis - clinical and experimental evaluation

Piroth, M. D.
2011

Strahlentherapie und Onkologie: journal of radiati, 187 (2011) S. 595

“...Langen, K. J....”

15

(18)F-Fluoroethyltyrosine-PET imaging in glioblastoma patients for radiotherapy planning and respones analysis - clinical and experimental evaluation.

High resolution BrainPET combined with simultaneous MRI

Herzog, H.
2011

Nuklearmedizin, 50 (2011) S. 74 - 82

“...Langen, K.J....”

16

Talk (non-conference)

Piroth, M.D.
2011

“...Langen, K.J....”

17

Contribution to a book
Contribution to a conference proceedings

(18)F-Fluoroethyltyrosine-PET imaging in glioblastoma patients for radiotherapy planning and respones analysis - clinical and experimental evaluation

Piroth, M.D.
2011

“...Langen, K.J....”

18

Assessment of treatment response in patients with glioblastoma multiforme using [18F]Fluoroethyl-L-Tyrosine PET

Galldiks, N.
2011

“...Langen, K.J....”

19

Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas

Floeth, F.W.
2011

European Journal of Nuclear Medicine and Molecular Imaging, 38 (2011) 4, S. 731 - 741

“...Langen, K.J....”

20